Dr. Saroj Prasad Panda Pediatric Hemato Oncologist in Bhubaneswar

Dr. Saroj Prasad Panda

Pediatric Hemato Oncologist, Bhubaneswar

MBBS, MD (Ped), FIAP (Ped H& O), DM (Ped Med Oncology)

  • 13 Years Experience
  • 1 Hospital

About

After completion of MD Pediatrics in June 2009 from S.C.B . Medical College Cuttack, I have been worked in the field of pediatric medical oncology and pediatric hematology in many prestigious institutes of India like PGI, Chandigarh (2 years), Wadia Hospital for Children, Mumbai (1 year), Tata Memorial Hospital, Mumbai (4 years) and Boston Children Hospital, United states (2 months). Presently I am working as an associate professor in medical (pediatric) oncology at IMS and Sum Hospital, Bhubaneswar.

Experience

Senior Registrar, Wadia hospital for Children, Mumbai, Mumbai May, 2011 -  July, 2012

DM Senior Registrar, Tata Memorial Hospital, Mumbai, Mumbai August, 2012 -  September, 2016

Senior Registrar, PGI Chandigarh, Chandigarh June, 2009 -  May, 2011

Specialities

  • Pediatric Hematology & Oncology

  • Pediatric Oncology

Procedures

  • Biopsy

  • Bone Marrow Biopsy

  • Chemotherapy

  • Lumbar Puncture

Practice Information

IMS & Sum Hospital, Bhubaneswar

IMS & Sum Hospital, Bhubaneswar

Kalinga Nagar, Bhubaneswar, Odisha - 751003

MON, TUE, WED, THU, FRI, SAT

09:00 AM - 04:00 PM

Achievements & Contributions

  •  Awarded travel scholarship for Pediatric GLOBE training program 2016, Boston Children Hospital/ Dana Farber Cancer Institute, Boston, United states
  • Awarded international travel award from American Society of Pediatric Hematology, for annual meeting ASPHO 2016, Minneapolis, United states.
  • Awarded international travel grant from International society for medical and pediatric oncology (ISMPO), for annual conference ISMO Asia-2015, Singapore
  •  Dr A.K.Samal Gold Medal from Indian Academy of Pediatrics, Orissa St Branch, in 2006.
  • D. S. Singh Gold Medal from Sambalpur University in Dec 2000
  • Pediatric oncology in India; opportunities and challenges. Oral presentation in Pediatric global oncology and blood disorder education program, Dana farber cancer institute, Boston United states, June 2016
  • Cladribine and cytarabine based chemotherapy in high risk and relapsed acute myeloid leukemia. Oral presentation at annual meeting of American society of pediatric hematology and oncology (ASPHO), Minnesota, Minneapolis, United states, May 2016
  • Pediatric oncology in India; the present perspective.  Oral presentation at annual meeting of American society of pediatric hematology and oncology (ASPHO), Minnesota, Minneapolis, United states, May 2016
  • Adolescent & young adult (AYA) survivors of childhood cancers- a challenge in after completion of therapy (ACT) clinic in resource constrained country. Oral presentation at Cancer Survivorship Symposium: Advancing Care and Research, at San Francisco, California. January 2016 
  • Outcome of Salvage Chemotherapy followed by Stem Cell Transplantation in Relapsed or Refractory Hodgkin Lymphoma in Children- A single center experience. Oral presentation at 47th Congress of the International Society for Paediatric Oncology SIOP-2015, at Cape Town, South Africa in October-2015
  • Audit of platinum induced ototoxicity in survivors of childhood cancers in late effect clinic at tertiary cancer centre, Poster presentation at 47th Congress of the International Society for Paediatric Oncology SIOP-2015, at Cape Town, South Africa in October-2015
  • Outcome of childhood APML treated with sequential ATO and ATRA based therapy: A retrospective study from a tertiary care centre. Oral presentation at 46th Congress of the International Society for Paediatric Oncology SIOP-2014, at Toronto, Canada in October-2014.
  • A prospective study to investigate the impact of malnutrition on the pharmacokinetics of anticancer drugs in young children. Concept presentation at Australia and Asia Pacific Clinical Oncology Research Development (ACORD) Workshop-2014,  at New South Wales, Australia, in September-2014.
  • Juvenile myelomonocytic leukemia, a neglected entity in the developing world: A single centre experience from India. Poster presentation at 44th Congress of the International Society for Paediatric Oncology SIOP-2012, at Barbican Centre in London, UK. October-2012.
  •  American Society of  Pediatric Hematology  and oncology (ASPHO)
  • Pediatric Hematology Oncology Chapter of IAP (IAP PHO)
  • Mumbai Hematology Group (MHG
  • Indian Academy of Pediatrics (IAP)
  • Indian Pediatric Oncology Group  (INPOG)
-->